Hongsong Chen
- Molecular Biology top 10%
- Immunology top 5%
- Epidemiology top 5%
- Hepatology top 2%
- Oncology top 10%
- Topics
- Hepatitis B Virus Studies (25 papers)Liver Disease Diagnosis and Treatment (19 papers)Hepatitis C virus research (18 papers)
- Cited by
- HepatologyImmunologyCancer Research
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hongsong Chen
100 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 767
- Immunology 544
- Epidemiology 490
- Hepatology 436
- Oncology 387
Countries citing papers authored by Hongsong Chen
This map shows the geographic impact of Hongsong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongsong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongsong Chen more than expected).
Fields of papers citing papers by Hongsong Chen
This network shows the impact of papers produced by Hongsong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongsong Chen. The network helps show where Hongsong Chen may publish in the future.
Co-authorship network of co-authors of Hongsong Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Hongsong Chen. A scholar is included among the top collaborators of Hongsong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongsong Chen. Hongsong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 25 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 15 | |
| 11 | 79 | |
| 12 | 9 | |
| 13 | Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. | 24 |
| 14 | 25 | |
| 15 | 5 | |
| 16 | [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma]. | 5 |
| 17 | 29 | |
| 18 | 13 | |
| 19 | 9 | |
| 20 | 58 |
About Hongsong Chen
Hongsong Chen is a scholar working on Hepatology, Urology and Epidemiology, having authored 111 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (19 papers) and Hepatitis C virus research (18 papers). The work is most often cited by research in Hepatology (436 citations), Immunology (544 citations) and Cancer Research (268 citations). Hongsong Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lai Wei, Xingwang Xie, Ran Fei, Henghui Zhang, Cong Xu, Xueyan Wang, Dongbo Chen, Gaixia He, Jinxue Zhou and Yanhui Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.